445303-24-2 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-bromo-phenyl)-1H-imidazole-4-carboxylic acid is used as a building block for the synthesis of biologically active molecules. The presence of the carboxylic acid group in 1-(3-bromo-phenyl)-1H-imidazole-4-carboxylic acid allows for further chemical modifications and the creation of new therapeutic agents with diverse pharmacological properties.
Used in Drug Development:
In the field of drug development, 1-(3-bromo-phenyl)-1H-imidazole-4-carboxylic acid is utilized as a starting material for the design and synthesis of new drugs. Its imidazole framework and functional groups make it a promising candidate for the development of compounds with potential applications in various therapeutic areas.
Further research and development of 1-(3-bromo-phenyl)-1H-imidazole-4-carboxylic acid may lead to the discovery of new therapeutic agents with diverse pharmacological properties, contributing to the advancement of the pharmaceutical industry and the treatment of various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 445303-24-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,5,3,0 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 445303-24:
(8*4)+(7*4)+(6*5)+(5*3)+(4*0)+(3*3)+(2*2)+(1*4)=122
122 % 10 = 2
So 445303-24-2 is a valid CAS Registry Number.
445303-24-2Relevant academic research and scientific papers
IMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX
-
Page/Page column 18, (2008/06/13)
This invention relates to novel imidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith. The compounds of the invention are useful in the treatment of central nervous system diseases and disorders,
Imidazole derivatives
-
, (2008/06/13)
Novel imidazole derivatives are disclosed. These compounds have a good affinity to the NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers, which have a key function in modulating neuronal activity and plasticity which makes them key players in mediating processes underlying development of CNS as well as learning and memory formation. These compounds are useful in the control or treatment of diseases mediated by this receptor.
